| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 1.19e-04 | 11 | 30 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 2.93e-04 | 17 | 30 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.81e-03 | 42 | 30 | 2 | GO:0098918 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.52e-03 | 182 | 30 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.60e-03 | 184 | 30 | 3 | GO:0022832 | |
| MousePheno | abnormal Kupffer cell morphology | 7.43e-06 | 21 | 26 | 3 | MP:0008114 | |
| MousePheno | abnormal locomotor coordination | 3.45e-05 | 726 | 26 | 8 | MP:0003312 | |
| MousePheno | abnormal hair cell morphology | 4.06e-05 | 214 | 26 | 5 | MP:0000045 | |
| MousePheno | impaired hearing | 4.94e-05 | 223 | 26 | 5 | MP:0006325 | |
| MousePheno | abnormal mechanoreceptor morphology | 5.85e-05 | 231 | 26 | 5 | MP:0000972 | |
| MousePheno | abnormal cochlear labyrinth morphology | 6.34e-05 | 235 | 26 | 5 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 6.34e-05 | 235 | 26 | 5 | MP:0003169 | |
| MousePheno | abnormal auditory brainstem response | 6.45e-05 | 576 | 26 | 7 | MP:0004738 | |
| MousePheno | abnormal hearing electrophysiology | 7.84e-05 | 594 | 26 | 7 | MP:0006335 | |
| MousePheno | abnormal cochlea morphology | 8.19e-05 | 248 | 26 | 5 | MP:0000031 | |
| MousePheno | abnormal membranous labyrinth morphology | 1.06e-04 | 262 | 26 | 5 | MP:0000035 | |
| MousePheno | ataxia | 1.14e-04 | 266 | 26 | 5 | MP:0001393 | |
| MousePheno | organ of Corti degeneration | 1.26e-04 | 53 | 26 | 3 | MP:0000043 | |
| MousePheno | abnormal motor coordination/balance | 1.27e-04 | 873 | 26 | 8 | MP:0001516 | |
| MousePheno | abnormal hearing physiology | 1.29e-04 | 643 | 26 | 7 | MP:0001963 | |
| MousePheno | hearing/vestibular/ear phenotype | 1.64e-04 | 905 | 26 | 8 | MP:0005377 | |
| MousePheno | neurodegeneration | 1.77e-04 | 468 | 26 | 6 | MP:0002229 | |
| MousePheno | abnormal ear morphology | 1.82e-04 | 470 | 26 | 6 | MP:0002102 | |
| MousePheno | abnormal ear physiology | 1.89e-04 | 684 | 26 | 7 | MP:0003878 | |
| MousePheno | cochlear degeneration | 2.01e-04 | 62 | 26 | 3 | MP:0000032 | |
| MousePheno | abnormal inner ear morphology | 2.09e-04 | 303 | 26 | 5 | MP:0000026 | |
| MousePheno | abnormal brain wave pattern | 2.21e-04 | 64 | 26 | 3 | MP:0004994 | |
| MousePheno | abnormal mononuclear phagocyte morphology | 2.28e-04 | 705 | 26 | 7 | MP:0008248 | |
| MousePheno | decreased synaptic depression | 2.56e-04 | 13 | 26 | 2 | MP:0002917 | |
| MousePheno | impaired righting response | 3.18e-04 | 180 | 26 | 4 | MP:0001523 | |
| MousePheno | abnormal amygdala morphology | 3.44e-04 | 15 | 26 | 2 | MP:0000818 | |
| MousePheno | abnormal liver sinusoid morphology | 4.11e-04 | 79 | 26 | 3 | MP:0008989 | |
| MousePheno | abnormal righting response | 4.32e-04 | 195 | 26 | 4 | MP:0002862 | |
| MousePheno | abnormal inner ear vestibule morphology | 4.43e-04 | 81 | 26 | 3 | MP:0000034 | |
| MousePheno | abnormal macrophage activation involved in immune response | 4.45e-04 | 17 | 26 | 2 | MP:0011075 | |
| MousePheno | premature death | 4.56e-04 | 1051 | 26 | 8 | MP:0002083 | |
| MousePheno | abnormal cochlear hair cell morphology | 4.93e-04 | 202 | 26 | 4 | MP:0002622 | |
| MousePheno | abnormal postural reflex | 5.02e-04 | 203 | 26 | 4 | MP:0002980 | |
| MousePheno | abnormal retina photoreceptor morphology | 5.31e-04 | 206 | 26 | 4 | MP:0001004 | |
| MousePheno | abnormal cochlear sensory epithelium morphology | 5.41e-04 | 207 | 26 | 4 | MP:0003308 | |
| MousePheno | abnormal organ of Corti morphology | 5.61e-04 | 209 | 26 | 4 | MP:0000042 | |
| MousePheno | axon degeneration | 6.23e-04 | 91 | 26 | 3 | MP:0005405 | |
| MousePheno | abnormal retina photoreceptor layer morphology | 6.24e-04 | 215 | 26 | 4 | MP:0003728 | |
| MousePheno | neuron degeneration | 6.76e-04 | 391 | 26 | 5 | MP:0003224 | |
| MousePheno | increased circulating renin level | 8.22e-04 | 23 | 26 | 2 | MP:0003352 | |
| MousePheno | increased or absent threshold for auditory brainstem response | 8.84e-04 | 236 | 26 | 4 | MP:0011967 | |
| MousePheno | absent startle reflex | 9.72e-04 | 25 | 26 | 2 | MP:0006359 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | 9.83e-04 | 1486 | 26 | 9 | MP:0002067 | |
| MousePheno | atelectasis | 1.02e-03 | 108 | 26 | 3 | MP:0001177 | |
| MousePheno | abnormal liver vasculature morphology | 1.02e-03 | 108 | 26 | 3 | MP:0009820 | |
| MousePheno | abnormal innate immunity | 1.17e-03 | 667 | 26 | 6 | MP:0002419 | |
| MousePheno | abnormal crista ampullaris morphology | 1.22e-03 | 28 | 26 | 2 | MP:0004249 | |
| MousePheno | circling | 1.29e-03 | 117 | 26 | 3 | MP:0001394 | |
| MousePheno | abnormal circulating renin level | 1.31e-03 | 29 | 26 | 2 | MP:0003349 | |
| MousePheno | abnormal macrophage morphology | 1.44e-03 | 463 | 26 | 5 | MP:0002446 | |
| MousePheno | abnormal somatic sensory system morphology | 1.52e-03 | 702 | 26 | 6 | MP:0000959 | |
| MousePheno | abnormal sensory neuron morphology | 1.59e-03 | 473 | 26 | 5 | MP:0000965 | |
| MousePheno | abnormal semicircular canal ampulla morphology | 1.59e-03 | 32 | 26 | 2 | MP:0008488 | |
| MousePheno | abnormal spinal cord morphology | 1.62e-03 | 278 | 26 | 4 | MP:0000955 | |
| MousePheno | impaired coordination | 1.66e-03 | 478 | 26 | 5 | MP:0001405 | |
| MousePheno | abnormal innervation pattern to muscle | 1.70e-03 | 33 | 26 | 2 | MP:0001052 | |
| MousePheno | abnormal brain internal capsule morphology | 1.80e-03 | 34 | 26 | 2 | MP:0008128 | |
| MousePheno | abnormal reflex | 1.80e-03 | 1294 | 26 | 8 | MP:0001961 | |
| MousePheno | abnormal somatic nervous system morphology | 2.13e-03 | 1025 | 26 | 7 | MP:0002752 | |
| MousePheno | abnormal phagocyte morphology | 2.23e-03 | 1033 | 26 | 7 | MP:0008251 | |
| MousePheno | abnormal gait | 2.40e-03 | 520 | 26 | 5 | MP:0001406 | |
| MousePheno | abnormal stationary movement | 2.48e-03 | 147 | 26 | 3 | MP:0001388 | |
| MousePheno | increased sensory neuron number | 2.61e-03 | 41 | 26 | 2 | MP:0006006 | |
| MousePheno | impaired macrophage chemotaxis | 2.61e-03 | 41 | 26 | 2 | MP:0003799 | |
| MousePheno | abnormal nervous system electrophysiology | 2.99e-03 | 329 | 26 | 4 | MP:0002272 | |
| MousePheno | decreased dendritic spine density | 3.00e-03 | 44 | 26 | 2 | MP:0020508 | |
| MousePheno | head tilt | 3.00e-03 | 44 | 26 | 2 | MP:0005191 | |
| MousePheno | abnormal long-term object recognition memory | 3.00e-03 | 44 | 26 | 2 | MP:0002801 | |
| Domain | Cl-channel_core | 8.92e-05 | 9 | 30 | 2 | IPR014743 | |
| Domain | - | 8.92e-05 | 9 | 30 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 8.92e-05 | 9 | 30 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 8.92e-05 | 9 | 30 | 2 | IPR001807 | |
| Domain | CBS_dom | 4.65e-04 | 20 | 30 | 2 | IPR000644 | |
| Domain | CBS | 4.65e-04 | 20 | 30 | 2 | PF00571 | |
| Domain | CBS | 4.65e-04 | 20 | 30 | 2 | PS51371 | |
| Pubmed | Construction and application of elastin like polypeptide containing IL-4 receptor targeting peptide. | 7.19e-07 | 2 | 30 | 2 | 24339977 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21092861 | ||
| Pubmed | Expression of CLCN voltage-gated chloride channel genes in human blood vessels. | 1.08e-05 | 6 | 30 | 2 | 10198195 | |
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 15254021 | ||
| Pubmed | 1.89e-05 | 1006 | 30 | 7 | 15226823 | ||
| Pubmed | Regulation of CLC-1 chloride channel biosynthesis by FKBP8 and Hsp90β. | 2.01e-05 | 8 | 30 | 2 | 27580824 | |
| Pubmed | 2.58e-05 | 9 | 30 | 2 | 20063299 | ||
| Pubmed | Changing expression of chloride channels during preimplantation mouse development. | 2.58e-05 | 9 | 30 | 2 | 23115349 | |
| Pubmed | 2.58e-05 | 9 | 30 | 2 | 28130356 | ||
| Pubmed | 9.70e-05 | 17 | 30 | 2 | 19641107 | ||
| Pubmed | Otx2 is a target of N-myc and acts as a suppressor of sensory development in the mammalian cochlea. | 9.70e-05 | 17 | 30 | 2 | 26160903 | |
| Pubmed | 1.22e-04 | 19 | 30 | 2 | 29665133 | ||
| Pubmed | Transcriptional regulation of cortical neuron migration by POU domain factors. | 1.35e-04 | 20 | 30 | 2 | 11859196 | |
| Pubmed | 2.31e-04 | 26 | 30 | 2 | 27122033 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.34e-04 | 139 | 30 | 3 | 16985003 | |
| Pubmed | Development and application of a DNA microarray-based yeast two-hybrid system. | 2.44e-04 | 141 | 30 | 3 | 23275563 | |
| Pubmed | 2.84e-04 | 689 | 30 | 5 | 36543142 | ||
| Pubmed | 3.68e-04 | 1139 | 30 | 6 | 36417873 | ||
| Pubmed | 4.20e-04 | 35 | 30 | 2 | 11013070 | ||
| Pubmed | 4.45e-04 | 36 | 30 | 2 | 9344654 | ||
| Pubmed | 4.96e-04 | 38 | 30 | 2 | 11779826 | ||
| Pubmed | 5.38e-04 | 441 | 30 | 4 | 12853948 | ||
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 5.43e-04 | 442 | 30 | 4 | 15815621 | |
| Pubmed | Onecut1 and Onecut2 redundantly regulate early retinal cell fates during development. | 6.35e-04 | 43 | 30 | 2 | 25228773 | |
| Pubmed | Pulmonary neuroendocrine cells function as airway sensors to control lung immune response. | 7.27e-04 | 46 | 30 | 2 | 26743624 | |
| Pubmed | New insights on the functional role of URG7 in the cellular response to ER stress. | 7.59e-04 | 47 | 30 | 2 | 29704455 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 4.33e-04 | 226 | 30 | 3 | chr2q37 | |
| Cytoband | 2q37.3 | 1.17e-03 | 77 | 30 | 2 | 2q37.3 | |
| Cytoband | 7q11.23 | 1.85e-03 | 97 | 30 | 2 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 1.35e-02 | 271 | 30 | 2 | chr7q11 | |
| GeneFamily | Chloride voltage-gated channels | 4.68e-05 | 10 | 19 | 2 | 302 | |
| Coexpression | GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN | 1.31e-05 | 127 | 30 | 4 | M441 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 9.04e-08 | 168 | 30 | 5 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-07 | 185 | 30 | 5 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | Endothelial-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.54e-07 | 187 | 30 | 5 | fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.58e-07 | 188 | 30 | 5 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-07 | 195 | 30 | 5 | fde8e7b38b3631109b95ef111c5f6e3f9878cfbd | |
| ToppCell | Endothelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.04e-07 | 198 | 30 | 5 | b93effa428ec036542fa21647dfef9589c64640f | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-07 | 198 | 30 | 5 | fb70a649e4e2edb32967328c1085dc5999c29a33 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.35e-06 | 173 | 30 | 4 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.26e-06 | 180 | 30 | 4 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | wk_15-18-Epithelial-PNS-Early_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.68e-06 | 183 | 30 | 4 | 7e8366ec8117d36cec67f77dcb0e9a6032d87fcb | |
| ToppCell | Endothelial-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 7.13e-06 | 186 | 30 | 4 | 796cbae2a417502aaf0891fc9c382bbfd88967fe | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 7.13e-06 | 186 | 30 | 4 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.28e-06 | 187 | 30 | 4 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-06 | 188 | 30 | 4 | a37edd8f9e4a4e336b5acbb0407d3d275975cee8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-06 | 189 | 30 | 4 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-06 | 190 | 30 | 4 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | Endothelial-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.75e-06 | 190 | 30 | 4 | 6e83fa0eb8cabe0ffb35375f16e6bf3755ec4977 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.75e-06 | 190 | 30 | 4 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.91e-06 | 191 | 30 | 4 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 7.91e-06 | 191 | 30 | 4 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.24e-06 | 193 | 30 | 4 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | (6)_Endothelial-C_(Capillary_Aerocyte_)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.24e-06 | 193 | 30 | 4 | f7f2dc6aff02d096a282835094d26d12b3b73e61 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 8.41e-06 | 194 | 30 | 4 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.41e-06 | 194 | 30 | 4 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | Endothelial-A-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.41e-06 | 194 | 30 | 4 | e656ac5539e59e321b46706cb8cc423b2c3358a0 | |
| ToppCell | Endothelial-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.41e-06 | 194 | 30 | 4 | abea887dd472c1a0d572e690bc8914c1b94712ad | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.41e-06 | 194 | 30 | 4 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 8.58e-06 | 195 | 30 | 4 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.58e-06 | 195 | 30 | 4 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.58e-06 | 195 | 30 | 4 | 517af3e6784f02c382df6f5691945eefaa9ec4ae | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.76e-06 | 196 | 30 | 4 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | 3'-Distal_airway-Endothelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.94e-06 | 197 | 30 | 4 | 9ffb823c0f3f23cc85f9fd3ca24f77817e90bd86 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.94e-06 | 197 | 30 | 4 | 7caa2c86dc4d50b57a7db8f7278d1588282ad6db | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 8.94e-06 | 197 | 30 | 4 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.94e-06 | 197 | 30 | 4 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.94e-06 | 197 | 30 | 4 | 6ac8d3e3f573e3848ab33e4df66dfaf8f948ea6c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.94e-06 | 197 | 30 | 4 | 951f18f326967206adbbfc422cce9eea3d2e0854 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.94e-06 | 197 | 30 | 4 | e3be7758a92f12e0a423394822957e1b7f995110 | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.12e-06 | 198 | 30 | 4 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-06 | 198 | 30 | 4 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | 368C-Endothelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.12e-06 | 198 | 30 | 4 | 9a2c2201baee51581733e183065298a97eba4553 | |
| ToppCell | Endothelial-A|World / lung cells shred on cell class, cell subclass, sample id | 9.12e-06 | 198 | 30 | 4 | dd096d4b9f428615f927f7df7cbf5cede0e0e605 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.12e-06 | 198 | 30 | 4 | 3aae7d146ebbb34da3239041a7c0334abff2597f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-06 | 198 | 30 | 4 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | (6)_Endothelial_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.12e-06 | 198 | 30 | 4 | f38f49d532fa6211f57e36ee494478bdd3f4f89c | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.12e-06 | 198 | 30 | 4 | 2400f8b8c51739ea2ae2b9f24f44eaeefa2bb6fc | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-06 | 198 | 30 | 4 | f88198e11e835ad53d339c312f8f7b7b0b5c02d3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.12e-06 | 198 | 30 | 4 | 3ae1e2b4ca77b94eaa24a8c990780aff47dface6 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.30e-06 | 199 | 30 | 4 | 3fea92affacd4c1f588fa81807df35d6c69b7241 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.30e-06 | 199 | 30 | 4 | 53b6a661d381b1ed3ea96e61e8bd1750de7d9fda | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-06 | 199 | 30 | 4 | a3ec743b978ba8fdf1677b4971b5731f50ddd30f | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.30e-06 | 199 | 30 | 4 | edb68a4f622a494f22fd7b25bc40ae0d58456cdb | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.30e-06 | 199 | 30 | 4 | 9c753043024871b1f1436fc39defac4da85e10cd | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.30e-06 | 199 | 30 | 4 | 993999adf346b4fd557989bc53c17eb0ccb996c9 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.30e-06 | 199 | 30 | 4 | 523e01f6a0abd9820697572e042a381aae8932dc | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.30e-06 | 199 | 30 | 4 | d017dd91f9b10038f1f83753a766e534da2dbe89 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.30e-06 | 199 | 30 | 4 | 45f9c03d2ed2d98d66086fb0251bd24e30c6f775 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-06 | 199 | 30 | 4 | 33f1669eeb701986b4dec409efdb6c06c3c41c2b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-06 | 199 | 30 | 4 | f35e9c05d0a0339ff691b38564da7aad8e9218aa | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.30e-06 | 199 | 30 | 4 | 448dd5a27d57627468c6b8347f1b6b1005aea004 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.30e-06 | 199 | 30 | 4 | 0d0d5cb821db16514192ad536849a8a04e22e637 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Capillary|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.30e-06 | 199 | 30 | 4 | 89f4db619fbed90f7fdf6ece7a671e514b5c6d76 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.30e-06 | 199 | 30 | 4 | dfd60380a29f99e187050933ee5252ec11c68a32 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.30e-06 | 199 | 30 | 4 | 772b3f60b83e29b958e1e70dadfd9f058ed4cb7c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.49e-06 | 200 | 30 | 4 | 2d962c9d63e9e5f1a06870e383609672e7b1738c | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Capillary|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | 6c0498a5868891e8e22c03469d00669b20249b1a | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.49e-06 | 200 | 30 | 4 | e6d36be0c4c569e27303bb4e4f34cd2187e9759d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-06 | 200 | 30 | 4 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.49e-06 | 200 | 30 | 4 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.49e-06 | 200 | 30 | 4 | 622206c33640cb2694fe158e8dc55515bb7bd4f5 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.49e-06 | 200 | 30 | 4 | 5ab588808c1fc384019413401ab4bf9bc06bf529 | |
| ToppCell | Biopsy_Control_(H.)-Endothelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | 6a9b6a4b4f204598290ae21c87ddb42ac95dfc4c | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Macrophages|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | d7b89a721988660d8010c804916f5d0ef2520ee2 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.49e-06 | 200 | 30 | 4 | e9913511a129bb3cee85e7ebf565b951dab91542 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Artery|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | 590d1c0f86f136c7e76ea107fbb8ac5ff1164386 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.49e-06 | 200 | 30 | 4 | 1ed1c673184f0c6aae04f90edbb1383b1c1f64d9 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.49e-06 | 200 | 30 | 4 | 5b4a54cd81bc4d9f5e92798362239e1aa1b70bee | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.49e-06 | 200 | 30 | 4 | 5109b417c066ecca0252008206b4f4b7a14c8702 | |
| ToppCell | Parenchymal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.49e-06 | 200 | 30 | 4 | 0e648e9eb96c83a94505d07323785a7a40997eb0 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.49e-06 | 200 | 30 | 4 | 2a1ba87ca4adf351ef8fa2b3154b86a5407b8f2f | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.49e-06 | 200 | 30 | 4 | 98f6a86fbbe5305c71dae91e7278de9813827935 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.49e-06 | 200 | 30 | 4 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.49e-06 | 200 | 30 | 4 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | abcbd5a156aa4fd51d284441388975c81c0b88ae | |
| ToppCell | Biopsy_IPF-Endothelial-Endothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | 39b4faad5700b3108f851f0df7fea3d298514465 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.49e-06 | 200 | 30 | 4 | 6567683f8f534310fecb44a6721909183fdc15ca | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-06 | 200 | 30 | 4 | 50fa0f8a3e490d5941b34e66a10158eba6c909d4 | |
| ToppCell | Biopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | 7ccd3b617838b39da814278dc0e12384013401ce | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.49e-06 | 200 | 30 | 4 | 7020045b933cb104fb99b79524cb0d4734b8636d | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | 9e5627e11288713aa9b622aae40e849dd6eacd29 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-06 | 200 | 30 | 4 | 7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Macrophages|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | c0c51719cf81512c50bfcc2fed883c867e522d2a | |
| ToppCell | Lung_Parenchyma-Control-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.49e-06 | 200 | 30 | 4 | 41ac6adbf61763aa8a81a0ed586c4a5542a42cc5 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.49e-06 | 200 | 30 | 4 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.49e-06 | 200 | 30 | 4 | dba96cda5f3b780a3d4171b61bc8aaddc1f5d466 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.49e-06 | 200 | 30 | 4 | 6a3ccd0ea742fa76282c2b0fbc59942b4ef47bb8 | |
| ToppCell | Biopsy_Control_(H.)-Endothelial-Endothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.49e-06 | 200 | 30 | 4 | 0242d465da2dfba0da629a43e152949c5192465b | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.49e-06 | 200 | 30 | 4 | 758840c31f2ddd7ccf7bf13252ebb48d33e89479 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.49e-06 | 200 | 30 | 4 | c37fe06a94e5779c56e01389869bb432d3bbaebc | |
| Disease | Williams-Beuren syndrome (is_implicated_in) | 3.11e-05 | 9 | 28 | 2 | DOID:1928 (is_implicated_in) | |
| Disease | schizophrenia, type 2 diabetes mellitus | 7.65e-04 | 43 | 28 | 2 | MONDO_0005090, MONDO_0005148 | |
| Disease | myopathy (implicated_via_orthology) | 9.53e-04 | 48 | 28 | 2 | DOID:423 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (is_implicated_in) | 1.39e-03 | 58 | 28 | 2 | DOID:7148 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKAPPAGDEALGGYG | 26 | Q13319 | |
| PAGALGAAAQSYGKG | 31 | Q08289 | |
| LAAKPGLDTYSLGGG | 56 | P54802 | |
| GYGILGKGPNLVESA | 361 | Q96I51 | |
| GALVPLGDALYVTGG | 506 | Q0D2K2 | |
| ALYGPKRAAGGAGAG | 166 | Q99684 | |
| YLGKPAAAKAPGAGG | 2281 | Q9UPA5 | |
| GELALAGAAAAYPGK | 346 | A8MYZ6 | |
| FGAYPVAAKARAGGG | 261 | Q96N66 | |
| GAAYGLAGLVKGLGI | 1396 | Q92616 | |
| LLASYAGEAGAGPAG | 326 | Q9UNW9 | |
| ALKYLGPVAAGGGAC | 81 | O95672 | |
| AVVGLGPPGEAGYKA | 591 | P24394 | |
| GSYPGIEGAGLALLA | 21 | O75319 | |
| GSGKVYQGPAKGAAD | 671 | P51659 | |
| GAGAKGYLGAVKPLA | 201 | O00257 | |
| GYLGAVKPLAGAAGA | 206 | O00257 | |
| LFGPKGVNIGGAGSY | 61 | P52943 | |
| AAYKAAKAGAGLGGV | 101 | P15502 | |
| AKAAKYGAAAGLVPG | 311 | P15502 | |
| AAAKAAKYGARPGVG | 376 | P15502 | |
| KYGAAGAGVLGGLVP | 451 | P15502 | |
| KYGAAVPGVLGGLGA | 656 | P15502 | |
| GGIPPAAAAKAAKYG | 726 | P15502 | |
| GAQPGALGGKCYLIG | 2361 | Q8TDX9 | |
| GGLGCPLAQYLAAAG | 91 | O95396 | |
| GKGPYQLSSLAAGGA | 1251 | Q6ZRI0 | |
| ARGNYDAAKRGPGGA | 56 | P0DJI9 | |
| YLAQGKAGGPAAAEP | 11 | Q587I9 | |
| EYLGGGSALDLLKPG | 96 | O00506 | |
| AAILGPAAGYLIGGA | 271 | Q96BD0 | |
| PGGYAVIGAAALTGA | 521 | P35523 | |
| YDGKARLAGEGLPGA | 686 | P35523 | |
| PGGYAVVGAAALAGA | 496 | P51788 | |
| PGLAAGPAGTYGKAV | 976 | O15417 | |
| ARLGAGAAGLYEPGA | 861 | Q9BYB0 | |
| GQALKGDGGLYSSLP | 326 | P08138 |